Morwenna Muir Selected Research

Morwenna Muir Research Topics

Disease

14	Neoplasms (Cancer) 01/2022 - 08/2008
10	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2010
4	Ovarian Neoplasms (Ovarian Cancer) 12/2019 - 08/2008
2	Carcinogenesis 01/2018 - 12/2012
2	Neoplasm Metastasis (Metastasis) 01/2018 - 06/2009
1	Triple Negative Breast Neoplasms 01/2022
1	Hemangiosarcoma (Angiosarcoma) 01/2019
1	Bites and Stings (Sting) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Lymphoma (Lymphomas) 01/2019
1	Hypersensitivity (Allergy) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2015
1	Osteolysis 05/2013
1	Bone Diseases (Bone Disease) 05/2013
1	Papilloma (Papillomatosis) 12/2012
1	Colonic Neoplasms (Colon Cancer) 07/2009
1	Hepatoblastoma 08/2008
1	Neuroblastoma 08/2008
1	Colorectal Neoplasms (Colorectal Cancer) 01/2008

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2010
5	Phosphotransferases (Kinase)IBA 01/2022 - 09/2015
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 05/2013
2	src-Family KinasesIBA 01/2022 - 01/2016
2	IntegrinsIBA 01/2018 - 12/2012
2	LigandsIBA 09/2015 - 05/2013
2	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 02/2013 - 08/2008
2	Estrogen ReceptorsIBA 07/2011 - 01/2010
1	bosutinibIBA 01/2022
1	integrin-linked kinaseIBA 01/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	AZD-0424IBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	UbiquitinIBA 11/2021
1	IronIBA 02/2020
1	Lapatinib (GW572016)FDA Link 02/2020
1	gedatolisibIBA 12/2019
1	wye (Y base)IBA 12/2019
1	2- amino- 8- (4- (2- hydroxyethoxy)cyclohexyl)- 6- (6- methoxypyridin- 3- yl)- 4- methylpyrido(2,3- d)pyrimidin- 7(8H)- oneIBA 12/2019
1	cadherin 5IBA 01/2019
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	TenascinIBA 01/2018
1	Tumor Viral Antigens (Large T Antigen)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Ribonucleases (Ribonuclease)IBA 01/2018
1	RibonucleotidesIBA 01/2018
1	Protein Isoforms (Isoforms)IBA 01/2017
1	Transcription Factors (Transcription Factor)IBA 01/2017
1	Docetaxel (Taxotere)FDA Link 01/2017
1	AZD 8931IBA 02/2016
1	AntigensIBA 09/2015
1	PND 1186IBA 09/2015
1	CytokinesIBA 09/2015
1	ChemokinesIBA 09/2015
1	Macrophage Colony-Stimulating FactorIBA 05/2013
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 05/2013
1	Insulin (Novolin)FDA Link 05/2013
1	Tyrosine Kinase InhibitorsIBA 05/2013
1	Insulin-Like PeptidesIBA 05/2013
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 02/2013
1	GTP-Binding Proteins (G-Protein)IBA 02/2013
1	Phorbol EstersIBA 12/2012
1	matriptaseIBA 01/2012
1	Letrozole (Femara)FDA LinkGeneric 07/2011
1	pertuzumabIBA 07/2011
1	Estrogen Receptor alphaIBA 07/2011
1	Trastuzumab (Herceptin)FDA Link 07/2011
1	Biomarkers (Surrogate Marker)IBA 01/2010
1	Estrogens (Estrogen)FDA Link 01/2010
1	Tamoxifen FDA LinkGeneric 01/2010
1	Taxoids (Taxanes)IBA 07/2009
1	matrigelIBA 06/2009
1	Fibronectins (Fibronectin)IBA 06/2009
1	Integrin alpha3IBA 06/2009
1	Small Interfering RNA (siRNA)IBA 06/2009
1	WW Domain-Containing OxidoreductaseIBA 06/2009
1	EnzymesIBA 01/2008

Therapy/Procedure

5	Therapeutics 01/2022 - 07/2011
1	Drug Therapy (Chemotherapy) 01/2017